Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Cash Flows (Unaudited)

v3.20.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Operating activities    
Net loss $ (19,595) $ (14,250)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation and amortization 1,099 1,137
Accretion of discount on marketable securities (41) (600)
Stock-based compensation 2,707 2,286
Recognition of expense (income) on derivative liability 7 (127)
Other (19) 73
Changes in operating assets and liabilities:    
Accounts receivable (2,781) (849)
Prepaid expenses and other assets 1,417 336
Accounts payable   476
Accrued compensation (3,073) (3,715)
Other liabilities (745) 397
Deferred rent (36) (7)
Deferred revenue 2,326 (5,302)
Net cash used in operating activities (18,734) (20,145)
Investing activities    
Purchases of marketable securities (3,600) (119,053)
Maturities of marketable securities 37,500 37,750
Sales of marketable securities 8,500 3,500
Purchases of equipment (763) (276)
Net cash provided by (used in) investing activities 41,637 (78,079)
Financing activities    
Proceeds from debt refinancing 25,000  
Payments of debt (10,000) (500)
Proceeds from exercise of common stock options 56 42
Proceeds from employee stock purchase plan 646  
Net cash provided by (used in) financing activities 15,702 (458)
Net increase (decrease) in cash, cash equivalents and restricted cash 38,605 (98,682)
Cash, cash equivalents and restricted cash at beginning of period 4,975 125,313
Cash, cash equivalents and restricted cash at end of period 43,580 26,631
Supplemental disclosure of cash flow information:    
Cash paid for interest 134 330
Supplemental disclosure of non-cash investing and financing information:    
Purchase of property and equipment included in accounts payable 255 63
Embedded interest associated with program fees 600 $ 860
Warrants issued to lenders as part of debt discount $ 619